Combined effect of GSTM1, GSTT1, and COMT genotypes in individual
Authors:
- 1 November 2004
- journal article
- research article
- Published by Springer Nature in Breast Cancer Research and Treatment
- Vol. 88 (1) , 55-62
Abstract
Our previous studies suggested that both catechol O-methyl transferase (COMT) and glutathione S-transferase (GST) M1 and T1 genotypes are associated with breast cancer risk. Here we extended the studies to evaluate the potential combined effect of these genotypes in individual breast cancer risk. Incident breast cancer cases (n = 202) and controls (n = 299) with no previous cancer were recruited from three teaching hospitals in Seoul in 1996-1999. Information on putative risk factors was collected by interviewed questionnaire. PCR-based methods were used for the genotyping analyses. Odds ratios (ORs) and 95% confidence (CIs) intervals were estimated by unconditional logistic regression after adjustment for known or suspected risk factors of breast cancer. Among pre-menopausal women the low activity associated (COMT *L) allele containing genotypes and the GSTM1 null genotype posed increased risks of breast cancer with ORs of 1.7 (95% CI = 1.0 - 2.8) and 1.7 (95% CI = 1.0-2.8), respectively. A marginally significant effect of GSTT1 null genotype was also observed when the total study population was considered (OR = 1.3, 95% CI = 1.0-2.1). When the combined genotype effects were examined, the concurrent lack of GSTM1 and GSTT1 genes posed a more than 2-fold risk of breast cancer (OR = 2.2, 95% CI = 1.2-3.9); this effect was mainly attributable in pre-menopausal women (OR = 3.2, 95% CI = 1.5-7.2). Moreover, the breast cancer risk increased in parallel with the number of COMT, GSTM1, and GSTT1 at-risk genotypes (p for trend = 0.003). This association was particularly clear in pre-menopausal women among whom combination of all three high-risk genotypes posed a 4.1-fold breast cancer risk (95% CI = 1.4-12.7) compared with pre-menopausal women without at-risk genotypes (p for trend = 0.001). The trend was more pronounced in women with BMI greater than 22 kg/m2 (p for trendp for trend = 0.013). These results suggest the combined effect between reproductive factors and GSTM1, GSTT1 andCOMT genotypes in human breast carcinogenesis.Keywords
This publication has 17 references indexed in Scilit:
- Molecular epidemiology of sporadic breast cancerMutation Research - Reviews in Mutation Research, 2003
- Body Mass Index, Serum Sex Hormones, and Breast Cancer Risk in Postmenopausal WomenJNCI: Journal of the National Cancer Institute, 2003
- Reproductive Factors, Glutathione S-Transferase M1 and T1 Genetic Polymorphism and Breast Cancer RiskBreast Cancer Research and Treatment, 2003
- GSTT1-null genotype is a protective factor against bladder cancerUrology, 2002
- Relationship between the Val158Met polymorphism of catechol O-methyl transferase and breast cancerPharmacogenetics, 2001
- Chapter 3: Endogenous Estrogens as Carcinogens Through Metabolic ActivationJNCI Monographs, 2000
- Genetic susceptibility to chronic obstructive pulmonary disease in Koreans: combined analysis of polymorphic genotypes for microsomal epoxide hydrolase and glutathione S-transferase M1 and T1Thorax, 2000
- Catechol-O-methyltransferase and breast cancer riskCarcinogenesis, 1998
- Relationship between the GSTM1 genetic polymorphism and susceptibility to bladder, breast and colon cancerCarcinogenesis, 1993
- ‘Hormonal’ risk factors, ‘breast tissue age’ and the age-incidence of breast cancerNature, 1983